Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £203.60m
BVT Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead Vt Share Chart

Update on the Offer for Subscription

6 Mar 2020 14:57

RNS Number : 3280F
Baronsmead Venture Trust PLC
06 March 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

Baronsmead Venture Trust plc

6 March 2020

Update on the Offer for Subscription

The Board of Baronsmead Venture Trust plc (the "Company") announced on 4 October 2019 that it had published a Prospectus in conjunction with Baronsmead Second Venture Trust plc in relation to an offer for subscription to each raise up to £20 million (before costs) with an over-allotment facility to each raise up to a further £5 million (the "Offer").

On 27 February 2020 the Company carried out a third allotment of shares under the Offer, issuing 6,262,000 new ordinary shares of 10 pence each in the Company ("New Shares"). Subsequently, at the annual general meeting of the Company held on 26 February 2020, shareholders approved the payment of a final dividend of 3.5 pence per share (the "Final Dividend"). However, the net asset value as at 31 January 2020 did not take account of the Final Dividend and accordingly the net asset value used to calculate the issue price which the New Shares were issued at was overstated by the amount of the Final Dividend.

On the basis of the adjusted net asset value the Company has issued an additional 281,420 New Shares resulting in 6,543,420 New Shares being issued in the third allotment under the Offer at an issue price of 80.10 pence.

Applications have been made for the additional New Shares to be issued pursuant to the Offer to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealing will commence in the additional New Shares to be issued pursuant to the Offer at 8.00 a.m. on 11 March 2020.

Share certificates and tax certificates in respect of the original issue of New Shares have not yet been issued. It is expected that share certificates and tax certificates showing the aggregate number of New Shares issued will be sent to the relevant Shareholders within 10 business days of the date of the allotment of the additional New Shares.

Total voting rights

Each Ordinary Share has one voting right. Following the issue of additional New Shares pursuant to the Offer, the Company will have 249,138,038 Ordinary Shares in issue (of which 20,731,897 Ordinary Shares are held in treasury). The total number of voting rights in the Company will therefore be 228,406,141 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Further information

For further information please contact.

Baronsmead VCT Investor Relations

020 3875 9862

baronsmeadvcts@greshamhouse.com

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEFLFESVEIRIII
Date   Source Headline
21st Dec 20185:24 pmRNSTransaction in Own Shares
6th Dec 20183:30 pmRNSNet Asset Value(s)
3rd Dec 20183:40 pmRNSTotal Voting Rights
3rd Dec 20187:00 amRNSChange of Registered Office
27th Nov 20185:59 pmRNSTransaction in Own Shares
23rd Nov 201811:29 amRNSAnnual Financial Report - Replacement
23rd Nov 20187:00 amRNSAnnual Financial Report
8th Nov 20185:06 pmRNSChange in management arrangements
6th Nov 20186:05 pmRNSNet Asset Value(s)
15th Oct 201812:15 pmRNSNet Asset Value(s)
1st Oct 201812:16 pmRNSTotal Voting Rights
27th Sep 20185:31 pmRNSTransaction in Own Shares
6th Sep 20184:00 pmRNSNet Asset Value(s)
9th Aug 20184:15 pmRNSIntention to Fundraise
9th Aug 20184:15 pmRNSDividend Declaration
7th Aug 201810:00 amRNSNet Asset Value(s)
13th Jul 20182:00 pmRNSNet Asset Value(s)
11th Jul 201812:27 pmRNSDirector Declaration
2nd Jul 20184:22 pmRNSTotal Voting Rights
28th Jun 20185:00 pmRNSTransaction in Own Shares
6th Jun 20184:30 pmRNSNet Asset Value(s)
1st Jun 201811:20 amRNSTotal Voting Rights
30th May 201811:38 amRNSTransaction in Own Shares
25th May 20187:00 amRNSHalf-year Report
14th May 20182:20 pmRNSDirector Declaration
4th May 20184:30 pmRNSNet Asset Value(s)
12th Apr 20183:00 pmRNSNet Asset Value(s)
3rd Apr 20181:02 pmRNSTotal Voting Rights
28th Mar 20185:39 pmRNSTransaction in Own Shares
6th Mar 20184:00 pmRNSNet Asset Value(s)
21st Feb 20183:15 pmRNSResult of AGM
7th Feb 201810:00 amRNSNet Asset Value(s)
18th Jan 201812:30 pmRNSNet Asset Value(s)
17th Jan 20183:30 pmRNSDirectorate Change
2nd Jan 20185:46 pmRNSTotal Voting Rights
20th Dec 20175:35 pmRNSTransaction in Own Shares
7th Dec 20172:30 pmRNSNet Asset Value(s)
5th Dec 20172:41 pmRNSDirectorate Change
1st Dec 201710:30 amRNSTotal Voting Rights
29th Nov 20175:29 pmRNSPublication of a supplementary prospectus
21st Nov 20176:00 pmRNSTransaction in Own Shares
21st Nov 20177:00 amRNSAnnual Financial Report
10th Nov 20174:15 pmRNSIssue of New Shares
7th Nov 20175:00 pmRNSNet Asset Value(s)
6th Nov 201711:15 amRNSOffer for Subscription - Update
1st Nov 20175:34 pmRNSDirector/PDMR Shareholding
1st Nov 20171:15 pmRNSTotal Voting Rights
26th Oct 20174:30 pmRNSIssue of New Shares
11th Oct 20175:30 pmRNSNet Asset Value(s)
4th Oct 20175:03 pmRNSPublication of a Prospectus - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.